Chief Executive Officer
Tue, May 16, 2023
May 16
3,007 shares @ $85.90
Decreased holdings by -1.00%
Net across this filing: +7.30% (+20,000 shares)
34th largest trade (out of 180)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +7.3% (+20,000 shares)
40% win rate · -5.3% median edge vs SPY (10 trades, 90-day · small sample)
Price 43% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology